Disease Prevention

2 trials

Sponsors

Kintampo Health Research Centre, Finlay Institute of Vaccines (IFV)

Conditions

COVID-19Cardiovascular Disease Cardiology

Unknown Phase

EFFECTIVENESS OF BEHAVIORAL MODIFICATION INTERVENTION TO REDUCE CARDIOVASCULAR DISEASE RISK FACTORS AMONGST PUBLIC SECONDARY SCHOOL STUDENTS IN BRONG

Active, not recruitingPACTR201709002540178

Kintampo Health Research CentreCardiovascular Disease Cardiology

Start: 2017-10-02Target: 848Updated: 2026-09-14

To evaluate the immunogenicity and safety of SOBERANA® 02 and SOBERANA® Plus as booster of immunity against the omicrom variant of SARS-CoV-2, in adult subjects

Active, not recruitingRPCEC00000424

Finlay Institute of Vaccines (IFV)COVID-19

Start: 2023-05-22Target: 306Updated: 2026-08-10